Welcome to LookChem.com Sign In|Join Free


  • or


Post Buying Request

551921-02-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

551921-02-9 Usage

General Description

4-(2-Chloro-pyridine-3-carbonyl)-piperazine-1-carboxylic acid tert-butyl ester is a chemical compound used in pharmaceutical research and drug development. It is a piperazine derivative containing a chloropyridine moiety and a carbonyl group. The tert-butyl ester functional group enhances the compound's stability and solubility, making it suitable for use in synthetic chemistry and medicinal chemistry. This chemical may have potential applications in the development of new drugs for various therapeutic areas, such as neurological disorders, cancer, and infectious diseases. Further research and testing are required to determine its specific pharmacological properties and potential uses in medicine.

Check Digit Verification of cas no

The CAS Registry Mumber 551921-02-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,5,1,9,2 and 1 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 551921-02:
139 % 10 = 9
So 551921-02-9 is a valid CAS Registry Number.



According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017


1.1 GHS Product identifier

Product name tert-butyl 4-(2-chloropyridine-3-carbonyl)piperazine-1-carboxylate

1.2 Other means of identification

Product number -
Other names HMS2665F10

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:551921-02-9 SDS

551921-02-9Relevant articles and documents

Anthranilic acid amide compound and its preparation and use


Paragraph 0057; 0058, (2018/03/24)

The invention belongs to the field of drug synthesis and relates to an anthranilamide compound with the general formula (I), in particular to an anthranilamide compound containing piperidine or piperazine, and pyridine analogues, a preparation method and medical application of the anthranilamide compound and the pyridine analogues. According to the compound, through a target gene Gli inhibitory activity test in an in-vitro Hedgehog signal pathway, a result shows that the compound has good Hedgehog signal pathway inhibitory activity, and a new antitumor drug can further be prepared. (Please see the formula in the specification).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)


What can I do for you?
Get Best Price

Get Best Price for 551921-02-9